Amelia Irvine

Amelia Irvine specializes in leading teams that analyze large, complex data sets to answer questions related to liability, causation, and damages. Her work ranges from supporting counsel through fact discovery to obtain relevant data and documents, to performing and overseeing economic and statistical analyses, to presenting these analyses in a digestible way for clients and courts. She has previously led teams in analyzing pharmaceutical promotion and prescribing of controlled substances, as well as calculating antitrust and breach of contract damages. She has experience supporting testifying experts and working with counsel through all phases of litigation—including settlement discussions and bench and jury trials.

BA, Economics (with honors) & Government (with honors), Georgetown University

SPOTLIGHT

Ms. Irvine was interviewed on an episode of Management Consulted's Strategy Simplified podcast about her role at Bates White, what it was like to join the firm as an experienced hire, Bates White's hiring process, and more.

• Supported testifying experts and counsel with data analysis of marketing, prescribing, and shipment data to evaluate causation and damages on behalf of Allergan concerning allegations of inappropriate marketing of prescription opioids in wide-ranging, multi-jurisdictional litigation. 
• Supported the expert in evaluating allegedly anticompetitive pharmaceutical “pay for delay” and line extension conduct and calculated damages for an opt-out plaintiff using claims and rebate data.
• Provided consulting support and supported the testifying expert in calculating damages using an “analogue analysis” on behalf of plaintiff regarding allegations of anticompetitive conduct that resulted in overcharges it paid. 
• Supported counsel with fact discovery, including by reviewing and evaluating transactional claims data, on a matter involving novel allegations of tortious contract interference and deceptive trade practices related to manufacturer copay assistance programs.